Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
Kaiser Permanente clinical research finds patients who have a site biopsied after a suspected cancer is biopsied are not more likely to develop a second cancer.
Kaiser Permanente research scientists Lawrence H. Kushi, ScD, and Bette Caan, DrPH, contribute to new American Cancer Society survivorship guideline.
KP Research Radio explores how oncologists used phone and video appointments to expand care options for cancer patients during the COVID-19 pandemic.
Regional program eliminated disparities in colorectal cancer death rates between Black and white members in Kaiser Permanente Northern California.
Kaiser Permanente study led by Minggui Pan, MD, PhD, and Laurel Habel, PhD, suggests ties among mutation type, tumor location, and survival.
The Patient-Centered Outcomes Research Institute-funded study will be co-led by research scientist and gastroenterologist Theodore R. Levin, MD, and focus on older adults with low-risk polyps.
KP Research Radio speaks with research scientist and gastroenterologist Jeffrey K. Lee, MD, MAS, about the studies that led to Kaiser Permanente’s successful screening program.
“This study demonstrates the importance at every BMI level of having more precise measures of muscle and fat to help identify those patients who are at high risk of developing cardiovascular disease,” said co-author Bette J. Caan, DrPH.
Coinciding with Colon Cancer Awareness Month (March), Kaiser Permanente Northern California received the National Colorectal Cancer Roundtable’s prestigious “80% by 2018” National Achievement Award, in recognition of screening rates over 83 percent for colorectal cancer.